77 related articles for article (PubMed ID: 10861105)
1. [Effects of pravastatin on hepatic plasminogen activator inhibitor 1 mRNA expression in rabbits with fatty liver].
Fan J; Chen L; Zeng M
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):70-2. PubMed ID: 10861105
[TBL] [Abstract][Full Text] [Related]
2. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
[TBL] [Abstract][Full Text] [Related]
3. Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
Harsch M; Gebhardt A; Reymann A; Lang G; Schliack M; Löser R; Braesen JH; Niendorf A
Br J Pharmacol; 1998 May; 124(2):277-82. PubMed ID: 9641543
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits.
Zhao SP; Li J; Xu Z; Wu J; Li Q; Ye H
Clin Chim Acta; 2004 Nov; 349(1-2):81-6. PubMed ID: 15469859
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononuclear cells in patients with primary nephrotic syndrome.
Wei JL; Cui HM; Ma CY
Eur J Med Res; 2007 May; 12(5):216-21. PubMed ID: 17513194
[TBL] [Abstract][Full Text] [Related]
6. [Expression and plasma activity of plasminogen activator inhibitor-1 infibrotic liver tissues].
Li Q; Qin C; Lao P
Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):209-11. PubMed ID: 10951619
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitor of plasminogen activator 1 (PAI-1) in hepatocellular carcinoma].
Zheng Q; Tang Z; Wu Z; Shi D; Song H
Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):474-6. PubMed ID: 11825444
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits.
Li JQ; Zhao SP; Li QZ; Cai YC; Wu LR; Fang Y; Li P
Clin Chim Acta; 2006 Aug; 370(1-2):57-62. PubMed ID: 16507303
[TBL] [Abstract][Full Text] [Related]
11. [Effects of tea polyphennols on hepatic lipase activity in rabbits with fatty liver].
Zhang XG; Chen YZ; Lei H; Wang ZB
Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):77-9. PubMed ID: 12648397
[TBL] [Abstract][Full Text] [Related]
12. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):688-94. PubMed ID: 12615670
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
Takayama M; Matsubara M; Arakawa E; Takada C; Ina Y; Hasegawa K; Yao K
Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
[TBL] [Abstract][Full Text] [Related]
14. [The effects of pravastatin on platelet-derived nitric oxide system in rabbits].
Ma LP; Kang MF; Yin SM; Nie DN; Xie SF; Wu YD; Li YQ; Feng JH; Xu LZ
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):539-42. PubMed ID: 16468331
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
[TBL] [Abstract][Full Text] [Related]
16. Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model.
Rosselli MS; Burgueño AL; Carabelli J; Schuman M; Pirola CJ; Sookoian S
Atherosclerosis; 2009 Sep; 206(1):119-26. PubMed ID: 19230890
[TBL] [Abstract][Full Text] [Related]
17. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
[TBL] [Abstract][Full Text] [Related]
18. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
[TBL] [Abstract][Full Text] [Related]
19. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 mRNA expression in cultured pigmented ciliary epithelial cells of the porcine eye.
Meyer MW; von Depka M; Wilhelm C; Schröder A; Erb C
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):679-86. PubMed ID: 12192463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
